DK400884D0 - Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-uinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt tl brug ved fremgangsmaaden - Google Patents

Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-uinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt tl brug ved fremgangsmaaden

Info

Publication number
DK400884D0
DK400884D0 DK400884A DK400884A DK400884D0 DK 400884 D0 DK400884 D0 DK 400884D0 DK 400884 A DK400884 A DK 400884A DK 400884 A DK400884 A DK 400884A DK 400884 D0 DK400884 D0 DK 400884D0
Authority
DK
Denmark
Prior art keywords
uinolines
octahydropyrazolo
tautomer
alkylated
trans
Prior art date
Application number
DK400884A
Other languages
English (en)
Other versions
DK400884A (da
Inventor
John Mehnert Schaus
Diane Lynn Huser
Richard Nolan Booher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK400884D0 publication Critical patent/DK400884D0/da
Publication of DK400884A publication Critical patent/DK400884A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK400884A 1983-09-26 1984-08-22 Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden DK400884A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53551983A 1983-09-26 1983-09-26

Publications (2)

Publication Number Publication Date
DK400884D0 true DK400884D0 (da) 1984-08-22
DK400884A DK400884A (da) 1985-03-27

Family

ID=24134591

Family Applications (1)

Application Number Title Priority Date Filing Date
DK400884A DK400884A (da) 1983-09-26 1984-08-22 Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden

Country Status (10)

Country Link
EP (1) EP0145121B1 (da)
JP (4) JPS6110583A (da)
KR (1) KR870001159B1 (da)
CA (1) CA1270488A (da)
DE (1) DE3484925D1 (da)
DK (1) DK400884A (da)
GB (1) GB2146984B (da)
GR (1) GR80200B (da)
HU (1) HU199836B (da)
IL (1) IL72729A (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6392722A (ja) * 1986-10-03 1988-04-23 Unitika Ltd 熱接着繊維およびその不織布
JPS6392723A (ja) * 1986-10-06 1988-04-23 Unitika Ltd 湿潤性複合繊維およびその不織布
JPS6420322A (en) * 1987-07-13 1989-01-24 Mitsubishi Petrochemical Co Conjugated fiber
JPH01204617A (ja) * 1988-02-09 1989-08-17 Chisso Corp 敷物
GB8828669D0 (en) * 1988-12-08 1989-01-11 Lilly Industries Ltd Organic compounds
KR20000008130A (ko) * 1998-07-10 2000-02-07 조정래 폴리에스터계 탄성사용 공중합물의 제조방법
CN103298343A (zh) 2011-01-07 2013-09-11 科赛普特治疗公司 类固醇和糖皮质激素受体拮抗剂组合疗法
WO2013130420A1 (en) * 2012-02-27 2013-09-06 Corcept Therapeutics, Inc. Phenyl heterocycloalkyl glucocorticoid receptor modulators
US8859774B2 (en) 2012-05-25 2014-10-14 Corcept Therapeutics, Inc. Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
DK3074011T3 (da) 2013-11-25 2019-09-30 Corcept Therapeutics Inc Octahydro-kondenserede azadecalin-glucocorticoidreceptormodulatorer
MX2019011543A (es) 2017-03-31 2019-12-16 Corcept Therapeutics Inc Moduladores del receptor de glucocorticoides para el tratamiento de cancer cervical.
US11234971B2 (en) 2018-12-19 2022-02-01 Corcept Therapeutics Incorporated Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
US11389432B2 (en) 2018-12-19 2022-07-19 Corcept Therapeutics Incorporated Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
AU2019404026B2 (en) 2018-12-19 2023-06-08 Corcept Therapeutics Incorporated Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
AU2020226863B2 (en) 2019-02-22 2023-04-06 Corcept Therapeutics Incorporated Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
UA128573C2 (uk) 2019-12-11 2024-08-14 Корсепт Терапьютікс Інкорпорейтед Способи лікування підвищення маси тіла, індукованого антипсихотичними засобами, за допомогою мірикориланту

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230861A (en) * 1979-01-22 1980-10-28 Eli Lilly And Company 1-And/or 7-substituted-6-hydroxy (or oxo)-3-decahydroquinoline carboxylic acids
US4198415A (en) * 1979-01-22 1980-04-15 Eli Lilly And Company Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
SU776048A1 (ru) * 1979-06-05 1983-09-23 Институт Бисорганической Химии Ан Бсср Производные 8-аза-16-оксагона-17-онов, про вл ющие противовоспалительную,мембраностабилизирующую и антифибринолитическую активность,и способ их получени
US4252945A (en) * 1979-07-11 1981-02-24 E. R. Squibb & Sons, Inc. Process for preparing pyrazolo[1,5-c]-quinazoline derivatives and novel intermediates
US4367231A (en) * 1979-09-14 1983-01-04 Eli Lilly And Company Method of using octahydro pyrazolo[3,4-g]quinolines
ES524452A0 (es) * 1982-11-03 1985-04-16 Lilly Co Eli Un procedimiento para la preparacion de derivados de pirazolo-quinolinas.

Also Published As

Publication number Publication date
JPH05194511A (ja) 1993-08-03
GB2146984B (en) 1987-04-08
EP0145121B1 (en) 1991-08-14
DK400884A (da) 1985-03-27
JPH0625251A (ja) 1994-02-01
GR80200B (en) 1985-01-02
JPS6110583A (ja) 1986-01-18
JPH0660183B2 (ja) 1994-08-10
JPH0568475B2 (da) 1993-09-29
HUT34750A (en) 1985-04-28
HU199836B (en) 1990-03-28
IL72729A0 (en) 1984-11-30
GB2146984A (en) 1985-05-01
GB8421159D0 (en) 1984-09-26
KR850002480A (ko) 1985-05-13
DE3484925D1 (de) 1991-09-19
KR870001159B1 (ko) 1987-06-13
EP0145121A2 (en) 1985-06-19
IL72729A (en) 1988-02-29
CA1270488A (en) 1990-06-19
EP0145121A3 (en) 1988-04-27
JPH05194527A (ja) 1993-08-03

Similar Documents

Publication Publication Date Title
NO854261L (no) 9-amino-1,2,3,4-tetrahydroakridin-1-01 og beslektede forbindelser og fremgangsmaate til fremstilling derav.
DK316784A (da) 1,2,4-triazol-3-on-derivater og fremgangsmaade til fremstilling deraf
NO852937L (no) Antibakterie-forstoffblandinger og framgangsmaate for framstilling av disse.
DK574581A (da) Delta2-1,2,4-triazolin-5-on-derivater og fremgangsmaade til fremstilling heraf
DK381485A (da) 1,2-benzisothiazol-3-yl-piperazinderivater og fremgangsmaade til fremstilling deraf
DK400884D0 (da) Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-uinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt tl brug ved fremgangsmaaden
DK445884A (da) Fremgangsmaade til fremstilling af 1,4-dialkyl-3-methyl-4-(3-substitueret phenyl)-piperidiner og mellemprodukt til brug ved fremgangsmaaden
DK321382A (da) Lineaere basiske polymerisater og fremgangsmaade til fremstilling heraf
NO862182D0 (no) Vekstmedium og fremgangsmaate til fremstilling av samme.
DK178084D0 (da) 1,3-dihydro-6-methyl-7-hydrosyfuro-(3,4-c)-pyridinderivater og fremgangsmade til fremstilling deraf
DK90382A (da) Platin-diamin-komlekser og fremgangsmaade til fremstilling deraf
KR900700420A (ko) 2,3-디플루오로벤젠의 제조방법
DK385884A (da) 2,6-substituerede 3,5-pyridin-dicarboxylsyre-derivater og fremgangsmaade til fremstilling heraf
NO834872L (no) Formede ildfaste metallboridgjenstander og fremgangsmaate for fremstilling av dem.
FR2554444B1 (fr) 1,25-dihydroxyvitamines d2 et procedes pour les preparer
DK195585A (da) 4'-deschlorrebeccamycin og fremgangsmaade til fremstilling af samme
DK511884D0 (da) Leukotrienantagonister og fremgangsmaade til fremstilling deraf
NO854453L (no) Fremgangsmaate og anordning for fremstilling av laminater.
DK165952C (da) 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf
DK593284D0 (da) Fremgangsmaade til fremstilling af nylon-blokcopolymere og middel tilbrug ved fremgangsmaaden
DK69684D0 (da) 2(1h)-pyridinonforbindelser og fremgangsmade til fremstilling heraf
IT8941550A0 (it) Metodo per ottenere composti polverulenti altofondenti inorganici e composizioni metalliche.
DK52885A (da) 1,3,2-dioxaborinan-forbindelser og fremgangsmaade til fremstilling heraf
DE3767813D1 (de) Stranggussverfahren.
DK537681A (da) 2,3-dihydropyraner og fremgangsmaade til fremstilling heraf

Legal Events

Date Code Title Description
ATS Application withdrawn